At present Sinclair is totally wrong buyer and investor for Prana. He is not interested in antibiotics. The first deal needs to be done with a company with a big antibiotic market. After that deal Sinclair is most likely not needed to bring money to Prana but he can be a good partner because of his interest in PBT434 and generally in extending human life.
PBT Price at posting:
4.0¢ Sentiment: None Disclosure: Held
